Market cap
₹7 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-3 Cr
-
ROE
-34.1 %
-
ROCE
-34.3 %
-
Industry P/E
23.97
-
EV/EBITDA
-12.6
-
Debt to Equity
0
-
Book Value
₹0.3
-
EPS
₹-0.1
-
Face value
1
-
Shares outstanding
220,742,560
10 Years Aggregate
CFO
₹-5.02 Cr
EBITDA
₹4.41 Cr
Net Profit
₹-4.92 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Adinath Bio-Lab
| 11.1 | 30.4 | 57.9 | 57.9 | 20.8 | -23.3 | -- |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
BSE Healthcare#
| 18.1 | 3.9 | 8.1 | 16.4 | 22.9 | 14.9 | 12.3 |
|
Company
|
2016
|
2015
|
2014
|
|---|---|---|---|
|
Adinath Bio-Lab
| 22.7 | 10.0 | -24.0 |
|
BSE Sensex
| 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Adinath Bio-Lab
|
0.3 | 6.6 | 0.7 | -2.5 | 4.3 | -34.1 | -- | 0.2 |
| 3,329.2 | 27,284.0 | 1,461.8 | 387.4 | 34.5 | 25.2 | 70.6 | 15.8 | |
| 824.0 | 16,187.0 | 7,784.0 | 688.5 | 10.6 | 14 | 23.3 | 2.8 | |
| 454.0 | 17,368.0 | 2,141.5 | 58.5 | 5.8 | 3.3 | 163.5 | 4.5 | |
| 832.3 | 20,630.3 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.1 | 4.2 | |
| 1,517.5 | 17,399.9 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 215.0 | 28,610.7 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,841.0 | 30,485.2 | 1,935.8 | 288.2 | 20.6 | 29.8 | 105.8 | 22.7 | |
| 413.8 | 16,709.9 | 3,600.2 | 221.0 | 9.7 | 5.6 | 75.6 | 3.5 | |
| 1,962.0 | 31,863.1 | 3,564.0 | 414.0 | 15.3 | 8.4 | 77.9 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Adinath Bio-Lab
Adinath Bio-Labs Limited trades in agricultural commodities and its allied products primarily in India. The company was incorporated in 1982 and is based in Kolkata, India.
-
Incorporated
1982
-
Chairman
--
-
Managing Director
--
-
Headquarters
Kolkata, West Bengal
-
Website
FAQs for Adinath Bio-Lab
What is the current share price of Adinath Bio-Lab Ltd Today?
The share price of Adinath Bio-Lab Ltd is ₹0.30 (BSE) as of 07-Mar-2017 IST. Adinath Bio-Lab Ltd has given a return of 20.84% in the last 3 years.
What is the current PB & PE ratio of Adinath Bio-Lab Ltd?
Since, TTM earnings of Adinath Bio-Lab Ltd is negative, P/E ratio is not available.
The P/B ratio of Adinath Bio-Lab Ltd is 0.23 times as on 07-Mar-2017, a 91 discount to its peers’ median range of 2.47 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2019 |
0.00 |
0.00 |
2018 |
0.00 |
0.00 |
2017 |
265.08 |
0.42 |
2016 |
29.23 |
0.14 |
2015 |
25.33 |
0.14 |
What is the 52 Week High and Low of Adinath Bio-Lab Ltd?
The 52-week high and low of Adinath Bio-Lab Ltd are Rs -- and Rs -- as of 28-Aug-2026.
What is the market cap of Adinath Bio-Lab Ltd?
Adinath Bio-Lab Ltd has a market capitalisation of ₹ 7 Cr as on 07-Mar-2017. As per SEBI classification, it is a company.
Should I invest in Adinath Bio-Lab Ltd?
Before investing in Adinath Bio-Lab Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.